Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Opioids could be used as an alternative to the controversial class of COX-2 arthritis and pain relief medications, according to an article published in the new Journal of Opioid Management.
Subscribe to our email newsletter
Opioids are often used in combination with other analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs) in particular. With the discovery of an increased risk of cardiovascular events affecting popular COX-2 inhibitors such as Merck & Co’s Vioxx and Pfizer’s Celebrex and Bextra, opioids could provide an important and viable substitute for pain management.
The Journal of Opioid Management is a new bimonthly publication led by editor-in-chief Dr Robert Enck, which is designed to provide doctors with important information regarding the correct use and management of opioids.
“There is a wide chasm between physician and nurse understanding of opioid use and pain management in general,” said Dr Enck, who also holds the same position with the American Journal of Hospice and Palliative Medicine. “Hopefully, the Journal of Opioid Management can close this gap.”